Younger age and valve oversizing are predictors of structural valve deterioration after pulmonary valve replacement in patients with tetralogy of Fallot 

Slides:



Advertisements
Similar presentations
Max B. Mitchell, MD  The Journal of Thoracic and Cardiovascular Surgery 
Advertisements

Manuel J. Antunes, MD, PhD, DSc 
Valve-sparing aortic root replacement and remodeling with complex aortic valve reconstruction in children and young adults with moderate or severe aortic.
Long-term results of right ventricular outflow tract reconstruction in neonatal cardiac surgery: Options and outcomes  Aditya K. Kaza, MD, Hong-Gook Lim,
Long-term follow-up after aortic valve replacement with Edwards Prima Plus stentless bioprostheses in patients younger than 60 years of age  Torsten Christ,
The effect of hematocrit during hypothermic cardiopulmonary bypass in infant heart surgery: Results from the combined Boston hematocrit trials  David.
Centers for Disease Control “increased-risk” organ donor: Not so risky?  Francis D. Pagani, MD, PhD  The Journal of Thoracic and Cardiovascular Surgery 
Long-term results after early primary repair of tetralogy of Fallot
Form ever follows function
William M. DeCampli, MD, PhD 
Biventricular Conversion After Single-Ventricle Palliation in Unbalanced Atrioventricular Canal Defects  Meena Nathan, MD, Hua Liu, MS, Frank A. Pigula,
It is still mostly about the mitral valve
Go on-pump or off-pump in diabetic patients?
Biventricular repair in patients with heterotaxy syndrome
Bicuspid aortic valve aortopathy: One size fits all?
Surgeons, valve repair in severely unbalanced atrioventricular septal defect, and the emperor's new clothes  David M. Overman, MD  The Journal of Thoracic.
Bigger The Journal of Thoracic and Cardiovascular Surgery
Risk-corrected impact of mechanical versus bioprosthetic valves on long-term mortality after aortic valve replacement  Ole Lund, MD, PhD, Martin Bland,
Early repair of hemitruncus: Excellent early and late outcomes
The lord of the rings  Antonio Miceli, MD, PhD 
Technical Performance Scores are strongly associated with early mortality, postoperative adverse events, and intensive care unit length of stay—analysis.
Aldo R. Castañeda, MD, PhD: Recipient of the Lifetime Achievement Award and 74th president of The American Association for Thoracic Surgery  Pedro J.
The variability of the mitral valve anatomy and terminology
Yang Zhang, MD, Haiquan Chen, MD, PhD 
Does the degree of preoperative mitral regurgitation predict survival or the need for mitral valve repair or replacement in patients with anomalous origin.
Support Your Specialty
Vladimiro L. Vida, MD, PhD, Fabio Zucchetta, MD, Giovanni Stellin, MD 
Transcatheter aortic valve replacement in intermediate-risk patients
Innovation and science: The future of valve design
It's not “just a shunt” but sometimes it should be…
Michele Gallo, MD, Gino Gerosa, MD 
Historical perspectives of The American Association for Thoracic Surgery: Pedro J. del Nido  John R. Spratt, MD, MA, Kristine J. Guleserian, MD, Sara.
A first start for lung transplantation?
Transcatheter aortic valve replacement and surgical aortic valve replacement: Both excellent therapies  J. James Edelman, MBBS(Hons), PhD, Vinod H. Thourani,
Sitaram M. Emani, MD, Breanna L
Tricuspid regurgitation or Ebsteinoid dysplasia of the tricuspid valve in congenitally corrected transposition: Is valvuloplasty necessary at anatomic.
Torsten Doenst, MD, PhD, Markus Richter, MD 
Fenton H. McCarthy, MD, MS, Nimesh D. Desai, MD, PhD 
Frank C. Spencer, MD, FACS, pioneering cardiothoracic surgeon
Attachment disorder in thoracoabdominal surgery
Bradley G. Leshnower, MD, Robert A. Guyton, MD, Richard J
Passing the torch The Journal of Thoracic and Cardiovascular Surgery
Sutureless valve implantation: Every detail counts
Biomaterials for heart valve replacement: Conjectures and refutations
Patients with unbalanced atrioventricular canal defects can undergo the Fontan operation with good outcomes  Sitaram M. Emani, MD  The Journal of Thoracic.
T. Brett Reece, MD  The Journal of Thoracic and Cardiovascular Surgery 
Hans-Joachim Schäfers, MD 
Long-term results of Freestyle stentless bioprosthesis in the aortic position: A single- center prospective cohort of 500 patients  Nicolas Amabile, MD,
The Journal of Thoracic and Cardiovascular Surgery
Discussion The Journal of Thoracic and Cardiovascular Surgery
Tissue valve, nitinol stent, or storage solution
The future of cardiac surgery training: A survival guide
Permanent pacemaker insertion following transcatheter aortic valve replacement: Not infrequent, not benign, and becoming predictable  Craig M. Jarrett,
Bicuspid aortopathy: Seeing the forest for the trees
Reliability of risk algorithms in predicting early and late operative outcomes in high-risk patients undergoing aortic valve replacement  Todd M. Dewey,
Outcome after repair of atrioventricular septal defect with tetralogy of Fallot  Jeffrey H. Shuhaiber, MD, Barbara Robinson, MD, Kimberlee Gauvreau, ScD,
After neoadjuvant chemoradiation therapy, predicted pulmonary function may be reduced by 10%  Benny Weksler, MD, MBA  The Journal of Thoracic and Cardiovascular.
“The more things change…”: The challenges ahead
Repetition is the mother of skill
Preoperative PFTs: The answer is blowing in the wind
Chordal replacement with polytetrafluoroethylene sutures for mitral valve repair: A 25- year experience  Tirone E. David, MD, Susan Armstrong, MSc, Joan.
Did you like Terminator 3 better than Terminator 2
Which biologic valve should we select for the 45- to 65-year-old age group requiring aortic valve replacement?  F. Dagenais, MD, P. Cartier, MD, P. Voisine,
How do we follow up our patients
Journal changes and initiatives
Designing valves: An art or science?
Lessons learned from Melody valve retrieved at transplantation
Primary left ventricular rehabilitation is effective in maintaining two-ventricle physiology in the borderline left heart  Sitaram M. Emani, MD, Emile.
Calpain inhibitors: The aspirin of the 21st century?
Paul Philipp Heinisch, MD, Thierry Carrel, MD 
Presentation transcript:

Younger age and valve oversizing are predictors of structural valve deterioration after pulmonary valve replacement in patients with tetralogy of Fallot  Peter C. Chen, MD, Maggie S. Sager, BA, David Zurakowski, PhD, Frank A. Pigula, MD, Christopher W. Baird, MD, John E. Mayer, MD, Pedro J. del Nido, MD, Sitaram M. Emani, MD  The Journal of Thoracic and Cardiovascular Surgery  Volume 143, Issue 2, Pages 352-360 (February 2012) DOI: 10.1016/j.jtcvs.2011.10.079 Copyright © 2012 The American Association for Thoracic Surgery Terms and Conditions

Figure 1 Freedom from reintervention and structural valve deterioration (SVD). PVR, Pulmonary valve replacement. The Journal of Thoracic and Cardiovascular Surgery 2012 143, 352-360DOI: (10.1016/j.jtcvs.2011.10.079) Copyright © 2012 The American Association for Thoracic Surgery Terms and Conditions

Figure 2 Effect of age on freedom from structural valve deterioration. PV, Pulmonary valve; PVR, pulmonary valve replacement. The Journal of Thoracic and Cardiovascular Surgery 2012 143, 352-360DOI: (10.1016/j.jtcvs.2011.10.079) Copyright © 2012 The American Association for Thoracic Surgery Terms and Conditions

Figure 3 Logistic regression curve predicting the probability of structural valve deterioration (SVD) according to indexed valve internal diameter in younger patients. The Journal of Thoracic and Cardiovascular Surgery 2012 143, 352-360DOI: (10.1016/j.jtcvs.2011.10.079) Copyright © 2012 The American Association for Thoracic Surgery Terms and Conditions